Nature Communications (Jan 2021)

Granzyme B inhibition reduces disease severity in autoimmune blistering diseases

  • Sho Hiroyasu,
  • Matthew R. Zeglinski,
  • Hongyan Zhao,
  • Megan A. Pawluk,
  • Christopher T. Turner,
  • Anika Kasprick,
  • Chiharu Tateishi,
  • Wataru Nishie,
  • Angela Burleigh,
  • Peter A. Lennox,
  • Nancy Van Laeken,
  • Nick J. Carr,
  • Frank Petersen,
  • Richard I. Crawford,
  • Hiroshi Shimizu,
  • Daisuke Tsuruta,
  • Ralf J. Ludwig,
  • David J. Granville

DOI
https://doi.org/10.1038/s41467-020-20604-3
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 14

Abstract

Read online

Pemphigoid diseases involve autoimmune mediated blistering and immunopathology of the upper dermis. Here, the authors implicate granzyme B in the immunopathology in multiple in vivo models of pemphigoid diseases and utilise a topical granzyme B inhibitor that attenuates disease phenotypes in vivo.